Skip to main content

Table 1 Baseline characteristics of patients with ischemic stroke and unknown symptom onset

From: Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial

Variable

Prior APT (n = 164)

No prior APT (n = 339)

P Value

Age, mean (SD), years

70.3 (8.2)

62.8 (12.1)

<  0.001

Female sex, No. (%)

60 (36.6)

118 (34.8)

0.692

Time between last seen well and symptom recognition, median (IQR), hours

7.52 (5.00–8.50)

7.00 (4.67–9.50)

0.085

Medical history/risk factors, No. (%)

 Arterial hypertension

120 (73.2)

146 (43.1)

<  0.001

 Diabetes mellitus

44 (26.8)

38 (11.2)

<  0.001

 Hypercholesterolemia

98 (59.8)

80 (23.6)

<  0.001

 Atrial fibrillation

27 (16.5)

32 (9.4)

0.010

 History of ischemic stroke

52 (31.7)

16 (4.7)

<  0.001

 History of TIA

17 (10.4)

6 (1.8)

<  0.001

 Current or former smoker

94 (58)

162 (50)

0.009

NIHSS score, median (IQR)

6 (4–12)

5 (4–9)

0.104

DWI lesion volume at baseline, median (IQR), ml

2.28 (0.80–9.61)

2.23 (0.70–7.70)

0.506

  1. SD standard deviation, IQR interquartile range, TIA transient ischemic attack, NIHSS National Institute of Health Stroke Scale, DWI diffusion weighted imaging